INNOVATIVE DEVELOPMENT OF PHARMACEUTICAL ENTERPRISES: MANAGEMENT APPROACHES AND IMPLEMENTATION MECHANISMS

The article reveals current aspects of managing the innovative development of pharmaceutical enterprises in the context of dynamic scientific and technological progress, intensifying competition, and growing demands for the efficiency, quality, and safety of medicinal products. The focus is on analyzing the specific characteristics of the pharmaceutical industry, which is distinguished by a high degree of knowledge intensity, lengthy research and development cycles, strict regulatory requirements, significant investment expenditures, and an elevated level of risk. The study substantiates the need to transform traditional innovation management models toward modern concepts based on the principles of open innovation, networked interactions, cross-sector cooperation, and an ecosystem approach. The evolution of managerial paradigms in the innovation sphere is analyzed, and key instruments for implementing innovation strategies are highlighted, including in-house research and development (R&D), strategic partnerships, mergers and acquisitions, technology licensing, collaboration with academic and research institutions, as well as the use of venture capital. Particular attention is given to digital transformations, including the implementation of artificial intelligence, big data analytics, cloud computing, blockchain technologies, and the Internet of Things in the processes of drug development, production, testing, and distribution. It is noted that these tools significantly accelerate development cycles, enhance the accuracy of efficacy forecasting, and optimize costs. The article identifies critical success factors for innovation management, such as an adaptive organizational structure, the presence of highly qualified personnel, effective strategic planning, sufficient resource support, institutional flexibility, and the ability to respond quickly to changes in the market environment. An original integrated model for managing the innovative development of pharmaceutical enterprises is proposed, combining tools of strategic management, risk management, and innovation project management.